Growing evidence suggests a close relationship between Alzheimer 0 s Disease (AD) and cerebral hypoxia. Astrocytes play a key role in brain homeostasis and disease states, while some of the earliest changes in AD occur in astrocytes. We have therefore investigated whether mutations
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release; CNS, central nervous system; DCF, 2 0 7 0 -dichlorofluorescein; DMEM, Dulbecco's modified Eagle's medium; ER, endoplasmic reticulum; F 0 , basal-fluorescence value before ATP injection; FCCP, carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone; F max , maximum florescence (triton elicited); F min , minimum florescence (MnCl 2 elicited); F t , fluorescence at a given time; H 2 DCFDA, 2 0 7 0 -dichlorofluorescein diacetate; HBSS, Hanks's balanced salt solution; InsP 3 , inositol trisphosphate; LDH, lactate dehydrogenase; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; NCX, Na + /Ca 2+ exchanger; OCR, oxygen consumption rate; OGD/reox, oxygen and glucose deprivation/reoxygenation; OGD, oxygen and glucose deprivation; PMCA, plasma membrane Ca 2+ ATPase; PS1, presenilin 1; ROS, reactive oxygen species; RRID, research resource identifier; SERCA, sarco/endoplasmic reticulum Ca 2+ -ATPase; TMRE, tetramethylrhodamineethyl esterperchlorate; WT, wild type. associated with AD increase astrocyte vulnerability to ischemia. Two astroglioma cell lines derived from APP SWE / PS1A246E (APP, amyloid precursor protein; PS1, presenilin 1) transgenic mice and controls from normal mice were subjected to oxygen and glucose deprivation (OGD) , an in vitro model of ischemia. Cell death was increased in the APP SWE Many studies, including observational epidemiological studies, have proposed a relationship between vascular risk factors and Alzheimer's disease (AD). The link between AD and cerebrovascular disease has been documented by the following findings: (i) AD may increase the likelihood of suffering stroke and vice versa (Pluta 2004a,b) , (ii) the accumulation of the b amyloid peptide in the brain of AD patients leads to neuronal (Hardy and Selkoe 2002) and vascular toxicity (Paris et al. 2004a,b) and also, (iii) AD and atherosclerosis share genetic and environmental risk factors such as ApoE e4 polymorphism, hypercholesterolemia, hypertension, obesity, and metabolic syndrome, among others (Casserly and Topol 2004) .
Astrocytes are the most abundant cells in the CNS. For decades, they were regarded as a passive supporting element in the brain, but this perception has dramatically changed in recent years. Astrocyte dysfunction seems to play a key role in the pathophysiology of many CNS diseases. For example, Verkhratsky et al. (2010) have proposed the astrocyte as being potentially responsible for the early synaptic failure observed in AD. Besides the classical structural properties, astrocytes have metabolic, homeostatic, signaling, and developmental functions. Astrocytes regulate the extracellular concentration of K + , glutamate, water, and pH (Chen and Swanson 2003) . They also encompass cerebral microcirculation with brain activity, as activity-induced Ca 2+ transients in astrocytes are related to changes in vascular pressure and, thus, participate in regulating cerebral blood flow.
It has been reported that both human and mouse models of AD show astrogliosis at late stages of the disease (Nagele et al. 2003; Olabarria et al. 2010) . However, at early stages of the disease, a degeneration/atrophy of these cells has been found in a triple transgenic mouse model of AD (Rodriguez et al. 2009; Olabarria et al. 2010) . Moreover, during ischemia, astrocytes take up excessive K + and glutamate (Rothstein et al. 1996) and release trophic factors which limit the extent of stroke (Anderson et al. 2003; Swanson et al. 2004) . After a stroke, astrocytes also play a crucial role in neuronal survival and recovery (Li et al. 2014) . Nevertheless, if astrocytes are compromised, they might contribute to increase neuronal cell death and brain damage (Zhao and Rempe 2010) . Therefore, our aim was to study the role of astroglia in the relationship between AD and brain ischemia. We employed a control astroglioma cell line and another line harboring the APPswe/PS1A246E AD-related mutations. We found that the AD-mutated astroglial cell line showed increased vulnerability to oxygen and glucose deprivation; we also found altered Ca 2+ homeostasis and impaired mitochondrial function in these cells, which may contribute to their vulnerability to ischemia.
Materials and methods
Materials RPMI media and heat-inactivated bovine fetal serum were purchased from Invitrogen (Madrid, Spain). Penicillin/streptomycin and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were obtained from Sigma-Aldrich (Madrid, Spain). Lactate dehydrogenase (LDH) cytotoxicity detection kit was acquired from Roche Diagnostics (Mannheim, Germany). Tetramethylrhodamine, ethyl ester, perchlorate (TMRE), 2 0 , 7 0 -dichlorofluorescein diacetate (H 2 DCFDA), dihydroethidium, Fluo-4, Rhod-2, and Hoechst were purchased from Molecular Probes (Invitrogen).
Culture and maintenance of astroglioma cell lines Both cell lines were a kind gift by Dr. Ricardo Martinez-Murillo (Instituto Cajal, Madrid, Spain), therefore, no local institutional approval was needed. Originally the cell lines were generated by injecting C57BL/6J wild-type (research resource identifier: 000664) and APPswe/PS1A246E (research resource identifier IMSR_ JAX:003378 bred to a C57BL/6J background) mice with the carcinogen 20-methylcholanthrene (20-MT) in cortices as previously described (Seyfried et al. 1992; Serrano et al. 2010; Ortega-Martinez 2015) . In Dr. Ricardo Martinez-Murillo's laboratory, 9-month-old APPswe/PS1A246E mice kindly donated by Professor Ignacio Torres (Instituto Cajal), were deeply anesthetized with pentobarbital (10 mg/kg) and atropine (90 mg/kg). Pellets of 20-MT were deeply implanted in the right parietal subcortex with the help of astereotaxic frame. Mice were observed periodically after the surgery and were sacrificed when their comfort or quality of life was compromised. The animals developed astrogliomas after 20-MT treatment, they were extracted, maintained in culture as a regular cell line. This procedure was carried out in accordance with the European Communities Council Directive (86/609/EEE) on animal experiments and with approval from the ethical committee of the Instituto Cajal (Institutional approval number 035/2013). The control cells correspond to the CT-2A cell line, which was generated by Prof. Seyfried (Boston, MA, USA). Both cell lines have been previously characterized (Ortega-Martinez 2015) . Both astroglioma cell lines were maintained in RPMI media supplemented with 10% of heat-inactivated fetal bovine serum (Invitrogen), 4 U/mL penicillin, and 4 lg/mL streptomycin (SigmaAldrich). Cells were grown in flasks containing supplemented media, maintained at 37°C and 5% CO 2 humidified air and passed once per week. Control and APPswe/PS1A246E cells were cultured in 48 well-plates at a seeding density of 20 000 cells per well. Cells were used after 48 h at passages between 4 and 13 after thawing. Cell lines were last authenticated by immunofluorescence during the review process. Both cell lines showed specific astrocytic markers (vimentin, S100B, and SOX2) and no neuronal markers (NeuN and MAP2) ( Figures S2 and S3 ). These cell lines have not been listed as a commonly misidentified cell line by the International Cell Line Authentication Committee.
Oxygen and glucose deprivation/reoxygenation model Oxygen and glucose deprivation/reoxygenation (OGD/reox) was used as an in vitro model of ischemia. For the OGD, the culture media was replaced by a solution containing (in mM): NaCl 137.93, KCl 5.36, CaCl 2 2, MgSO 4 1.19, NaHCO 3 26, KH 2 PO 4 1.18, and 2-deoxyglucose 11 (Sigma-Aldrich) previously bubbled with a gas mixture containing 95% N 2 /5% CO 2 . Thereafter, cell plates were placed in an airtight chamber (Billups and Rothenberg, Inc., del Mar, CA, USA) and were exposed for 5 min to 95% N 2 /5% CO 2 gas flow to ensure purging of residual oxygen and the chamber was closed tightly and maintained at 37°C for 4 h. Control cells were treated with a solution similar to the OGD solution but containing 15 mM glucose instead of 2-deoxyglucose and placed in a normoxic atmosphere during 4 h. At the end of the 4 h OGD period, cells were withdrawn from the ischemia chamber and the OGD solution was replaced by control culture media and kept for a further 14 h in an incubator at 37°C in a humidified atmosphere (see protocol in Fig. 1a) . At the end of the experiment, viability quantification by MTT and/or LDH was carried out. reactive oxygen species (ROS) levels were analyzed by DCF fluorescence and mitochondrial membrane potential by TMRE staining.
Measurement of cell viability
Cell viability was measured using MTT (Sigma-Aldrich) and LDH techniques. The MTT method is based on the ability of mitochondrial dehydrogenases of living cells to reduce MTT to produce a precipitated formazan, as previously described (Liu et al. 1997) . MTT (5 lg/mL) was incubated during 2 h at 37°C; then, the media was removed and the precipitated formazan was solubilized with 300 lL of dimethyl sulfoxide. Cellular viability was quantified spectrophotometrically at a wavelength of 550 nm. Basal condition, that is, cells not exposed to OGD/reox, was considered as 100% viability and the rest of the variables were normalized with respect to that value.
Measurement of LDH activity was assessed using a cytotoxicity cell death kit (Roche Diagnostics) according to the manufacturer's instructions. LDH is a cytosolic enzyme that is released to the extracellular media in necrotic cell death. Extracellular and intracellular LDH were measured taking extracellular media or cellular lysates, respectively, and total LDH activity was determined as the sum of extracellular plus intracellular measurements. Results were expressed as the percentage of extracellular LDH compared with total LDH activity.
Fluorescence assays
Mitochondrial membrane potential was assessed by TMRE (100 nM) fluorescence. TMRE is a positively charged dye that accumulates within the relatively negative milieu of mitochondria leading to fluorescence emission at 574 nm when excited at 549 nm. The more negative the mitochondrial membrane is, the more TMRE accumulates in the mitochondria, leading to an increase in fluorescence.
The fluorescent indicator H 2 DCFDA was used to measure ROS production. Cells were incubated with 10 lM H 2 DCFDA which is a cell-permeable dye that diffuses into cells. After entering into the cell, it is deacetylated by intracellular esterases and in the presence of ROS it is oxidized to DCF, a green fluorescent dye whose wavelengths of excitation and emission are 485 and 520 nm, respectively. Results were normalized using the cell-permeable DNA stain Hoechst (1 lg/mL). Wavelengths of excitation and emission of Hoechst were 350 and 460 nm, respectively. Cells were equilibrated with all fluorescent dyes for 20 min at 37°C.
Fluorescence intensity was measured using an inverted NIKON eclipse T2000-U microscope (Nikon Instruments, Europe, Badhoevedorp, Netherlands). Images were taken at magnifications of 20x. Analysis of fluorescence imaging data was performed using Metamorph program version 7.0 (Molecular Devices, LLC, Sunnyvale, CA, USA). The average intensity of control cells in basal condition was considered 100% so that the rest of variables were normalized to this value.
Cytosolic Ca
2+ measurements by fluorescence microscopy
The 
Measurement of mitochondrial oxygen consumption
Mitochondrial oxygen consumption rate (OCR) was assessed using the XF24 Extracellular Analyzer (Seahorse Bioscience, North Billerica, MA, USA). Briefly, cells were plated in XF24 cell culture microplates (Seahorse Bioscience) and cultured during 24 h in order to obtain a homogenous monolayer. For equilibration, cells were incubated with unbuffered Dulbecco's modified Eagle's Medium (DMEM) supplemented with 25 mM glucose, 1 mM pyruvate, and 2 mM glutamine at 37°C in a CO 2 -free incubator during 1 h prior to the experiment. A calibration cartridge (Seahorse Bioscience) was equilibrated overnight and afterward loaded with unbuffered DMEM (port A) and 5 lg/mL oligomycin (port B), and 1 lM rotenone plus 1 lM antimycin A (port C), all obtained from SigmaAldrich. Non-mitochondrial respiration was calculated as OCR after the administration of rotenone + antimycin and this value was subtracted to all measures. Basal respiration was calculated as the OCR after administration of unbuffered DMEM and ATP turnover as the difference between Basal Respiration and OCR after oligomycin administration. Results were normalized to total protein content using Pierce BCA protein assay kit (Thermo Fisher Scientific, Madrid, Spain).
ATP measurement ATP production was determined with an ATP Assay Kit (Fluorometric, ab83355; Abcam, Cambridge, UK). ATP production rate was determined following the protocol described by the manufacturer. Firstly, cells were washed with cold phosphate-buffered saline and resuspended in 100 lL of ATP assay buffer. Then, the cells were quickly homogenized by pipetting up and down, centrifuged for 2 min at 4°C (18 000 g) to remove any insoluble material. Thereafter, the supernatant was collected and transferred to a clean tube and kept on ice. ATP assay buffer (400 lL ) and 100 lL of icecold perchloric acid (4 M) were added to the homogenate to deproteinate the samples. The homogenates were vortexed briefly and incubated on ice for 5 min. The homogenate was centrifuged at 18 000 g for 2 min at 4°C and the supernatant was transferred to a fresh tube. The supernatant volume was measured and an equal volume of ice-cold 2 M KOH was added. Finally, the homogenate was centrifuged at 18 000 g for 15 min at 4°C and the supernatant was collected. ATP reaction mix (50 lL) and 50 lL of sample were added to each well and incubated at 24°C for 30 min, protected from light. The samples were measured on a microplate reader at 535/587 nm.
Mitochondrial and cytosolic Ca 2+ assays using a microplate reader of ATP was injected to each well to obtain a final concentration of 10 lM. Fluorescence measurements were carried out using a microplate reader (FLUOstar Optima; BMG, Labtech, Ortenberg, Germany). Wavelengths of excitation and emission were 494/ 506 nm (Fluo-4 AM) and 552/581 nm (Rhod-2 AM), respectively. At the end of the experiment, 5% triton and 1 mM MnCl 2 were added to each well to calculate maximum fluorescence (F max ) and minimum fluorescence (F min ), respectively. ATP-induced responses were expressed as a percentage of the fluorescence value at each time point (% F t ). This was calculated by subtracting the fluorescence at a given time (F t ) to the basal-fluorescence value before ATP injection (F 0 ) and divided by the F max À F min fluorescence, calculated using the following formula:
The maximum % fluorescence intensity for Fluo-4 (Maximum % 
Results
Vulnerability of APPswe/PS1A246E astroglioma cells to OGD/reoxygenation To study the influence of AD mutations on astroglial responses to an ischemic episode, we exposed control and APPswe/PS1A246E mutated astroglial cell lines to oxygen and glucose deprivation followed by reoxygenation (OGD/ reox). Both cell lines were subjected to 4 h of OGD followed by 14 h of reoxygenation (Fig. 1a) . Cell viability was measured as LDH released into the extracellular media and MTT metabolism. The OGD/reox paradigm increased cell death far more in the APPswe/PS1A246E cells than in controls; LDH release was increased by 25% and MTT reduction was decreased by 40%, while in the control cell line LDH release was increased by 11% and MTT metabolism was unchanged ( Fig. 1c and d) . Thus, APPswe/PS1A246E mutations increased astrocyte vulnerability to ischemia. In line with these results, bright field microphotographs (Fig. 1b) , showed a decrease in cell number in APPswe/ PS1A246E cells when compared to control after OGD/reox. In the analysis of % LDH release after OGD/reox (Fig. 1c) To study this phenomenon further, both astroglioma cell lines were subjected to the OGD/reox protocol and afterward mitochondrial membrane potential and rates of ROS generation were measured by fluorescence microscopy. In basal conditions, the TMRE fluorescence was twofold greater in APPswe/PS1A246E than in control cells (Fig. 1e) , indicating an increased mitochondrial membrane potential; while the rate of ROS generation was increased by almost threefold (Fig. 1f) . After OGD/reox, control or APPswe/PS1A246E did not show a significant increase in TMRE fluorescence when compared to their respective basal conditions (Fig. 1e) . However, the production of free radicals after OGD/reox was potentiated in the APPswe/PS1A246E astroglioma cell line by threefold when compared to control cells after OGD/reox, demonstrating significant positive interaction between the presence of the mutation and ROS production (Fig. 1f) . Of note, we assessed whether TMRE was working in nonquenching mode by adding carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone and oligomycin to the cultures (data not shown). In the analysis of TMRE fluorescence after OGD/reox (Fig. 1e) In the analysis % DCF/Hoechst fluorescence after OGD/reox (Fig. 1f) , the two-way ANOVA revealed a significant effect of treatment [F 1,27 = 30.46, p < 0.001], a significant effect of genotype [F 1,27 = 28.24, p < 0.001], and a significant treatment 9 genotype interaction [F 1,27 = 5.546, p < 0.05].
Ca
2+ -dependent cell death in the APPswe/PS1A246E astroglioma cell line Ca 2+ plays a major role both in the pathophysiology of and cell death associated with AD and stroke. It is also a second messenger that allows astroglial cells to communicate through the astrocytic network by propagating Ca 2+ waves (Sheppard et al. 1997) . We therefore explored the role of Ca 2+ in the vulnerability to ischemia of the cells expressing APPswe/ PS1A246E mutations. We performed the OGD/reox experiments increasing the concentration of extracellular Ca 2+ from 0.414 mM (the Ca 2+ concentration in RMPI media) to 5 mM (Fig. 2a) . As previously observed (Fig. 1d) , the vulnerability of APPswe/PS1A246E cells to OGD/reox was greater than that of control cells. Furthermore, this vulnerability was dependent on the extracellular concentration of Ca 2+ ( Fig. 2b) : increasing extracellular Ca 2+ concentration to 5 mM, significantly decreased cell viability by 18% in the APPswe/PS1A246E cells compared to the 0.414 mM Ca 2+ + OGD/reox group; while it had no significant impact on viability of control cells. Moreover, the difference in cell viability at 0.4 mM Ca 2+ + OGD/reox between control and APPswe/PS1A246E cells was 17%, whereas it increased to 27% at 5 mM Ca 2+ +OGD/reox. In Fig. 2b (Fig. 3a) . ATP at 10 lM and 100 lM increased cytosolic Ca 2+ in both cell lines (Fig. 3b and c) ; nevertheless, the maximal [Ca 2+ ] c peak values (Fig. 3d) , the area under the curve (AUC) (Fig. 3e) , and the width (Fig. 3f) of the intracellular Ca 2+ transients were all increased in the APPswe/PS1A246E cells. Furthermore, at the end of the measurement period (120 s), the basal cytoplasmic Ca 2+ levels had still not returned to baseline in the APPswe/ PS1A246E cells. In the maximal peak analysis (Fig. 3d) (Fig. 3e) , the two-way ANOVA revealed a nonsignificant effect of ATP [F 1,9 = 0.067, p > 0.05], a significant effect of genotype [F 1,9 = 44.09, p < 0.0001], and no ATP 9 genotype interaction [F 1,9 = 0.198, p > 0.05]. In the width analysis (Fig. 3f) , the two-way ANOVA revealed a nonsignificant effect of ATP [F 1,9 = 0.1441, p > 0.05], a significant effect of genotype [F 1,9 = 22.38, p < 0.01], and no ATP 9 genotype interaction [F 1,9 = 8.570e-005, p > 0.05].
To further study the differences observed in Ca 2+ homeostasis, control and APPswe/PS1A246E cell lines were exposed to thapsigargin to measure ER-stored Ca 2+ . By blocking the sarco/endoplasmic reticulum Ca 2+ -ATPase pump, thapsigargin produces a [Ca 2+ ] c signal derived from Ca 2+ release through ER leak channels, which may be amplified by Ca 2+ -induced Ca 2+ release. The kinetics of the response were strikingly faster in APPswe/PS1A246E astroglioma cells (Fig. 4a) , although there was no significant difference in the AUC (t 11 = 1.8, p = 0.073, Fig. 4b ), there was a 40% decrease in Tmax (U = 0.0, p = 0.0012, Fig. 4c ), more than a twofold decrease in peak width (t 11 = 8.8, p < 0.0001, Fig. 4d) , and a 2.5-fold increase in the maximal peak (t 11 = 11.74, p < 0.0001, Fig. 4e ). On the other hand, CCE was not significantly different in the two astroglioma cell lines in terms of maximal peak (t 8 = 1.869, p = 0.0985, Fig. 4f ). However, cytoplasmic Ca 2+ levels remained higher in astroglioma cells carrying the mutation (final steady state) at the end of the experiment (U = 3.00, p = 0.0152, Fig. 4g ). In order to analyze whether this change in Ca 2+ homeostasis is detrimental for the APPswe/PS1A246E, we measured cell viability after incubating the cells with the same concentration of thapsigargin overnight. Interestingly enough, only the APPswe/PS1A246E cells showed an increase in cell death (twofold increase) after thapsigargin treatment (Fig. 4h) . Taken together, these results would further suggest that the increased vulnerability to OGD/reox found in APPswe/PS1A246E astroglioma cell line seems to be related to Ca 2+ dysregulation. In the statistical analysis of % LDH release after thapsigargin treatment (Fig. 3f) , the two-way ANOVA revealed a non-significant effect of treatment [F 1,20 in response to beta amyloid, mitochondrial respiration is impaired, ROS generation is increased, and mitochondrial membrane potential is altered (Casley et al. 2002; Abramov et al. 2004; Abeti et al. 2011 ). As we already found that basal ROS levels and TMRE fluorescence were increased in the APPswe/PS1A246E cell line, we measured different aspects of mitochondrial function.
Firstly, to assess whether mitochondrial Ca 2+ handling was perturbed in the APPswe/PS1A246E cells, we measured [Ca 2+ ] c and mitochondrial Ca 2+ concentration ([Ca 2+ ] mit ) levels on exposure to 10 lM ATP. Surprisingly, we did not observe differences in [Ca 2+ ] mit responses between the cell lines (t 6 = 0.9060, p = 0.3998, Fig. 5a and b) measured by Rhod-2 fluorescence. However, [Ca 2+ ] c levels were increased in the APPswe/PS1A246E-mutated cells in accordance with our previous experiments (U = 0.0, p = 0.0286, Fig. 5c and d) .
We also measured the rate of oxygen consumption in both cell lines and found that the mutations were associated with a decrease in basal respiration (t 6 = 7.104, p = 0.0004, Fig. 5e and h) and coupled respiration (t 6 = 5.474, p = 0.0016, ATP turnover, Fig. 5f and h) . Furthermore, ATP production in APPswe/PS1A246E cells was significantly reduced compared to control cells (t 4 = 2.156, p = 0.0973, Fig. 5g and h) .
Taken together, APPswe/PS1A246E cells showed mitochondrial dysfunction that might contribute to an increased vulnerability to OGD/reox. Moreover, taking into account: (i) the mitochondrial membrane hyperpolarization, (ii) the increased ROS production, and (iii) the decreased ATP levels found in APP/swe/PS1A246E cell line, we hypothesize that these results could be because of impaired activity of the ATP synthase.
Discussion
We have found that an astrocytic cell line carrying the APPswe/PS1A246E mutations is more vulnerable to ischemia. They also present altered calcium signals and mitochondrial dysfunction that might contribute to the increased sensibility to ischemia.
The relationship between AD and ischemia has been well documented previously (Casserly and Topol 2004; Gorelick 2004) . Coexistence of stroke and AD occurs more than by chance alone and they are known to exacerbate each other (Kalaria et al. 1993; Pasquier et al. 1998) . On the other hand, interest in the role of astrocytes in stroke and AD has been growing in recent years with increasing evidence that they contribute significantly to the progression of both diseases (Anderson et al. 2003; Swanson et al. 2004; Verkhratsky et al. 2010; Li et al. 2014) . Thus, we aimed to find whether AD mutations could compromise astrocyte function in such a way that they are more vulnerable to ischemia and so clarify the potential role for astrocyte pathophysiology in the relationship between AD and stroke.
To address this question, we chose two astroglioma cell lines, control and APPswe/PS1A246E, derived from wild- type and APPswe/PS1A246E mice, respectively. Interestingly, the cell line expressing both mutations associated with familial AD, showed higher vulnerability to the ischemiareperfusion stimulus compared to the control cell line ( Fig. 1c and d) . This higher vulnerability to ODG/reox was accompanied by higher mitochondrial membrane potential and increased ROS production ( Fig. 1e and f) . In line with our results, Zhen et al. (2012) also observed increased cell death in hippocampal slices subjected to OGD in APPswe/ PS1DE9 mice compared to wild-type mice and in the CA1 region of the same mice that underwent global cerebral ischemia. Astrocytes are relatively resistant to hypoxia (Panickar and Norenberg 2005) , thus it is not surprising that the control cell line was not affected by the OGD/reox protocol defined by MTT metabolism. However, it is worth noting that astrocytic cell death has also been observed in wild type astrocytes in models of ischemia in vivo (Li et al. 1995; Chen et al. 1997) and that the contribution of this cell type to excitotoxicity after ischemia has been previously documented (Rossi et al. 2000) . The increased vulnerability of APPswe/PS1A246E astrocytes to the ischemic insult could be related to the higher incidence of stroke in AD patients and highlights the possible role of astrocytes in these pathological events. As Ca 2+ plays a major role in cell death associated with AD and stroke (Goldberg and Choi 1993; Weiss et al. 1994; Begley et al. 1999; Lee et al. 1999; Schneider et al. 2001) , we performed the same experiment but increasing the concentration of extracellular Ca 2+ and observed a potentiation of cell death in the AD-mutated cell line (Fig. 2) , highlighting the role of Ca 2+ signaling in OGD/ reox vulnerability in the mutated cell line.
Given that APP and PS1 mutations have been described to affect Ca 2+ homeostasis in different cell models (Guo et al. 1996 (Guo et al. , 1997 Johnston et al. 2006) we decided to study Ca 2+ regulation in both cell lines. When ATP was used to trigger ER Ca 2+ release mediated by InsP 3 , the mutated cell line responded with an increased cytoplasmic [Ca 2+ ] with increased maximal peak, AUC, and width (Fig. 3) . Our results agree with studies reported by Grolla et al. (2013) in which the authors reported that cytoplasmic Ca 2+ levels after stimulation of neuron-glial co-cultures with a metabotropic receptor agonist were increased in cultures treated with beta amyloid. Interestingly enough, the lowest concentration used in this study (1 lM ATP), elicited a Ca 2+ signal in APPswe/ PS1A246E but not in the control cell line which points to an increased response to this pathway. Supporting our data, Johnston et al. (2006) , described that astrocytes transfected with a PS1 harboring a mutation linked to familial AD, showed Ca 2+ oscillations at lower ATP and glutamate concentrations compared to astrocytes transfected with wild-type PS1. To corroborate the alteration in Ca 2+ regulation after ATP incubation, we induced the release of Ca 2+ from the ER by blocking the sarco/endoplasmic reticulum Ca 2+ -ATPase pump through thapsigargin treatment. Again, we observed an increase in the maximal peak but this time because of a change in kinetics rather than to an increased overall Ca 2+ release, as there were no changes in the AUC, but the width and the Tmax were decreased (Fig. 4) . After depleting the intracellular stores of Ca 2+ , we re-added Ca 2+ to the extracellular solution to activate CCE. We observed an increase in the final height and, interestingly, the decay of the signal in the APPswe/PS1A246E cell line seemed to be decreased, which may be because of a failure in Ca 2+ extrusion to the extracellular media. Taken together, these data show that APPswe/PS1A246E mutations lead to increased Ca 2+ concentration in the cytosol after stimulation. These results are of particular interest as Ca 2+ signaling in astrocytes has been postulated to contribute to the progression of AD (Gomez-Gonzalo et al. 2017) . Excessive Ca 2+ responses are known to lead to apoptotic and necrotic cell death, which is demonstrated by the fact that thapsigargin induced Ca 2+ cell death in APPswe/PS1A246E cell line but not in the control (Fig. 4h) .
Mitochondrial abnormalities in the APP/PS1 mouse model have been widely studied by several authors in cultured neurons (Sompol et al. 2008 ), brain slices (Dragicevic et al. 2011) , or isolated brain mitochondria (Dragicevic et al. 2011) , although the role of astrocytes on this issue has been less explored. Thus, we decided to study mitochondrial function in our experimental setting. We found that the astroglioma cells carrying the APPswe/PS1A246E mutations displayed mitochondrial membrane hyperpolarization and increased ROS levels ( Fig. 1e and f) . They also showed a decrease in ATP levels (Fig. 5g) . The increased mitochondrial membrane potential in APPswe/PS1A246E cells may support increased ROS production, as described elsewhere (Lee et al. 2002) . Interestingly, iPSC-derived neurons with the 10 + 16 MAPT mutation, which induces an increase in the production of 4R tau isoforms, leads to mitochondrial hyperpolarization, ROS overproduction, lower ATP production, and altered bioenergetics (Esteras et al. 2017) , similar to the results described in this study. Altogether, these data indicate that the APPswe/PS1A246E mutations might inhibit ATPase synthase activity, which would increase mitochondrial membrane potential, increase ROS production, and decrease ATP production. Several studies have found a decrease in the activity of the mitochondrial ATPase synthase in AD (Cha et al. 2015; Beck et al. 2016) . Schmidt et al. (2008) have identified APP as a binding partner of the alpha subunit of the mitochondrial ATP synthase and Ab interacts with oligomycin sensitivity conferring protein, component of the ATPase synthase, leading to a loss of function (Beck et al. 2016) . Moreover, an abnormal accumulation of APP has been found in the mitochondria of AD patients (Devi et al. 2006 ). Thus, APP or Ab could be abnormally regulating mitochondrial ATPase synthase activity in the APPswe/PS1A246E cells by directly binding to it and decreasing its activity.
Finally, taking into account mitochondrial dysfunction associated with AD mutations and their implication in Ca 2+ homeostasis, we aimed to compare Ca 2+ responses in cytosol and mitochondria in both cell lines. Interestingly enough, the Ca 2+ transients observed in the mitochondria after ATP stimulation did not differ between control and APPswe/ PS1A246E astrocytic cell lines. Thus, cell death may not be because of Ca 2+ overload in the mitochondria but as a result of Ca 2+ overload in the cytosol. Of note, it has been described that cytosolic Ca 2+ overload leads to cell death by overactivating the proteolytic enzyme calpain leading to fragility and rupture of the plasma and ER membrane (Garcia-Dorado et al. 2012; Murphy et al. 2014) . However, compromised mitochondrial function through increased ROS production and a hyperpolarized membrane potential may also participate in this process.
In conclusion, we have found that astrocytes carrying the APPswe/PS1A246E exert alterations in calcium regulation and mitochondrial function which could contribute to the increased vulnerability to OGD/reox. Thus, AD mutations may alter the normal physiology of astrocytes, to the extent that they are vulnerable to stimuli that are harmless in healthy conditions with the obvious impact for neuronal function and survival. However, these results still need further confirmation in primary cultures and in an in vivo model.
Supporting information
Additional Supporting Information may be found online in the supporting information tab for this article: Figure S1 . Expression of APP and PS1 in the APPswe/ PS1A246E astroglioma cell line. Figure S2 . Purity of the cell lines demonstrated by all cells expressing the astrocytic marker S100B and Hoechst. Figure S3 . Characterization of the astroglioma cell lines by immunofluorescence. ] mit levels measured by Rhod-2 (a) and [Ca 2+ ] c levels measured by Fluo-4 (c) fluorescence after 10 lM ATP addition and its quantification (b and d). (e) Mitochondrial basal respiration, (f) ATP turnover and, (g) ATP levels in both control and APPswe/PS1A246E astroglioma cell lines. Representative graph of oxygen consumption rate for control cells and APPswe/PS1A246E (h). Data are shown as means and SEM of n = 3-4 independent experiments. **p < 0.01, ***p < 0.001 versus control. Student's t-test. Each 'n' represents an independent experiment, corresponding to different passages of the cell lines.
